BibTex RIS Cite

G PROTEINS IN HEALTH AND DISEASE

Year 1999, Volume: 12 Issue: 1, 46 - 49, 03.12.2016

Abstract

...

References

  • Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 1992;17:383-387.
  • Rens-Domiano S, Hamm HE. Structural and functional relationships of heterotrimeric G- proteins. FASEB J 1995;9:1059-1066.
  • Offermans S, Simon Ml. Organization of transmembrane signalling by heterotrimeric G proteins in Cancer Surveys. Cell Signalling. Tooze J. Parker PJ, Pawson T eds. HewYork: Cold Spring Harbor Laboratory Press, 1996:177-198.
  • Heer E. Heterotrimeric G proteins: Organizers of transmembrane signals. Cell ¡995:80:249-257.
  • iioel JP, Hamm HE, Sigler PB. The cryctal structure of the GTP y S - bound alpha subunit of the rod G protein, nature 1993:366:654-663.
  • Lambright DG, Hoe! JP, Hamm HE, Sigler PB. The 1.8A cysta! structure of transducin a-GDP. Structural determinants for activation of a heterotrimeric G- protein a subunit, nature 1994:369:621-628.
  • Gilman AG, G proteins: Transducers of receptorgenerated signals. Annu Rev Biochem 1987;56:615-649.
  • Logothetis DE, Kurachi Y., Galper J., neer EJ, Clapham DE. The fiy subunits of GTP - binding proteins activate the muscarinic K+ channel in heart, nature 1987:325:321-326.
  • Clapham DE, neer EJ, new roles for G protein Py dimers in transmembrane signaling, nature 1993:365:403-406.
  • Malbon CC. Heterotrimeric G-proteins and development. Biochem Pharmacol 1997:53:1-4.
  • Strittmater SM, Valenzuela D, Kennedy TE, neer EJ, Eishman PIC. Gocr is major growr cone protein subject to regulation by GAP-43. nature 1990;344:836-84!.
  • Marmara Medical Journal Volume 12 No: 1 January 1999
  • Strittmater SM, Valenzuela D, Kennedy TE, rieer EJ, Fishman MC. Mediation by G-proteins of signals that cause collapse of growth cones. Science 1993:77- 79.
  • Mullaney I, Milligan G. Elevated levels of the guanine nucleotide binding protein, G0, are associated with differentiation of neuroblastoma x glioma hybrid cells. FEBS Lett 1989,244:113-118.
  • Gierschik F, Morrow B, Milligan G, Rubin C, Spiegel A. Changes in the guanine nucleotide-binding proteins, G,- and G0, during differentiation of 3T3-LI cells. FEBS Lett 1986; 199:103-106.
  • Watkins DC, Rapiejko PJ, Ros M, Wang Fl, Malbon CC. G-protein mRITA levels during adipocyte differentiation. Biochem Biophys Res Commun. 65:929-934.
  • Wang FI, Watkins DC, Malbon CC. Antisense oligodeoxynucleotides to Gs protein cx-subunit sequence accelerate differentiation of fibroblasts to adipocytes, nature 1992;358:334-337.
  • Denis-Ftenriot D., Lacasa D, Goldsmith PK, De Mazancourt P, Giudicelli Y. Site-related differences in G-protein a subunit expression during adipogenesis in vitro: Possible key role for Gq/I / a in the control of preadipocyte differentiation. Biochem Biophys Res Commun 1996:220:443-448.
  • Galvin-Parton PA, Watkins DC, Malbon CC. Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells. J Biol Chem 1990;265:17771-17774.
  • Gao P, Malbon CC. Differentation of F9 teratocarcinoma stem cells to primitive endoderm is regulated by the Gia2/Gsa axis via phospholipase C and not adenylyl cyclase. J Biol Chem 1996:2 71:3069 7-30698.
  • Amatruda TT, Steele DA, Zlepak VZ, Simon Ml. Cin 16, a G protein a subunit specifically expressed in hematopoietic cells. Proc ITatl Acad Sci USA 1991;88:5587-5591.
  • Meibner JD, Brown G A, Mueller WFI, Scheibe RJ. Retinoic acid -mediated decrease of Gas protein expression Involvement of Gas in the differentiation of tlL-60 myeloid cells. Exp Cell Res 1996:225:1 12-121.
  • Tiagata K, Okano Y, ITozawa Y. Identification of heterotrimetric GTP-binding proteins in human megakaryoblastic leukemia cell line, MEG-01, and their alteration during cellular differentiation. Life Sci 1995;57:1675-1681.
  • Kesselring F, Spicher K, Porzig FI. Changes in G protein pattern and in G protein -dependent signaling during erythopoietin- and dimethylsulfoxide- induced differentiation of murine erythroleukemia cells. Blood 1994;84:4088-4098.
  • Tenailleau S, Corre I, Flermouet S. Specific expression of heterotrimeric G proteins G ¡2 and G ¡g during human myeloid differentiation. Exp Flematol 1997;25:927-934.
  • Spiegel AM, Shenker A, Weinstein LS. Receptor- effector coupling by G-proteins: Implications for normal and abnormal signal transduction. Endocr Rev 1992;13:536-565.
  • Spiegel AM. Defects in G protein- coupled signal transduction in human disease. Annu Rev Physiol 1995;58:143-1 70.
  • Lyons J. Landis CA, Flarsh G, Vallar L et al. Two G protein oncogenes in human endocrine tumors. Science 1990;249:655-659.
  • dementi E, Malgaretti H, Meldolesi J, Taramelli R. A new constitutively activating mutation of the Gs protein a subunit-gsp oncogene is found in human pituitary tumors. Oncogene 1990;5:1059-1061.
  • OSullivan C, Barton CM, Staddon SL, Brown CL, Lemoine FIR. Activating point mutations of the gsp oncogene in human thyroid adenomas. Molecular Carcinogenesis 1991:4.345-349.
  • Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. IT Engl J Med 1991 ;325:1688-1695.
  • Scwindinger WF, Francomano CA, Levine MA. Idenfiction of a mutation in the gene encoding the a subunit of the stimulatory G protein of adenylyl cyclase in Me Cune- Albright Syndrome. Proc ITatl Acad Sci USA 1992;89:5152-5156.
  • Suarez FIG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. gsp mutations in human thyroid tumors. Oncogene 1991;6:677-679.
  • Tordjman K, Stern IT, Ouaknine G et al. Activating mutations of the Gsa gene in non-functioning pituitary tumors. J Clin Endocrinol Metab 1993;77:765-769.
  • Yoshimato K, Iwahana FI, Fukuda A, Sano T, Itakurra M. Rare mutations of the Gsa subunit gene in human endocrine tumors. Cancer 1993:72:1386- 1393.
  • Williamson EA, Daniels M, Foster S, Kelly WF, Kendall-Taylor P, Harris PE. Gsa and Cij2u mutations in clinically non-functioning pituitary tumors. Clin Endocrinol 1994;41:815-820.
  • Williamson EA, Ince PG, Flarrison D, Kendall-Taylor P, Harris PE. G-protein mutations in human pituitary and adrenocorticotrophic hormone-secreting adenomas. Eur. J. Clin Invest 1995;25:128-131.
  • Williamson EA, Johnson SJ, Foster S, Kendall-Taylor P, Harris PE. G-protein gene mutations in patients with multiple endocrinopathies. J Clin Endocrinol Metab 1995:80:1702-1705.
Year 1999, Volume: 12 Issue: 1, 46 - 49, 03.12.2016

Abstract

References

  • Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 1992;17:383-387.
  • Rens-Domiano S, Hamm HE. Structural and functional relationships of heterotrimeric G- proteins. FASEB J 1995;9:1059-1066.
  • Offermans S, Simon Ml. Organization of transmembrane signalling by heterotrimeric G proteins in Cancer Surveys. Cell Signalling. Tooze J. Parker PJ, Pawson T eds. HewYork: Cold Spring Harbor Laboratory Press, 1996:177-198.
  • Heer E. Heterotrimeric G proteins: Organizers of transmembrane signals. Cell ¡995:80:249-257.
  • iioel JP, Hamm HE, Sigler PB. The cryctal structure of the GTP y S - bound alpha subunit of the rod G protein, nature 1993:366:654-663.
  • Lambright DG, Hoe! JP, Hamm HE, Sigler PB. The 1.8A cysta! structure of transducin a-GDP. Structural determinants for activation of a heterotrimeric G- protein a subunit, nature 1994:369:621-628.
  • Gilman AG, G proteins: Transducers of receptorgenerated signals. Annu Rev Biochem 1987;56:615-649.
  • Logothetis DE, Kurachi Y., Galper J., neer EJ, Clapham DE. The fiy subunits of GTP - binding proteins activate the muscarinic K+ channel in heart, nature 1987:325:321-326.
  • Clapham DE, neer EJ, new roles for G protein Py dimers in transmembrane signaling, nature 1993:365:403-406.
  • Malbon CC. Heterotrimeric G-proteins and development. Biochem Pharmacol 1997:53:1-4.
  • Strittmater SM, Valenzuela D, Kennedy TE, neer EJ, Eishman PIC. Gocr is major growr cone protein subject to regulation by GAP-43. nature 1990;344:836-84!.
  • Marmara Medical Journal Volume 12 No: 1 January 1999
  • Strittmater SM, Valenzuela D, Kennedy TE, rieer EJ, Fishman MC. Mediation by G-proteins of signals that cause collapse of growth cones. Science 1993:77- 79.
  • Mullaney I, Milligan G. Elevated levels of the guanine nucleotide binding protein, G0, are associated with differentiation of neuroblastoma x glioma hybrid cells. FEBS Lett 1989,244:113-118.
  • Gierschik F, Morrow B, Milligan G, Rubin C, Spiegel A. Changes in the guanine nucleotide-binding proteins, G,- and G0, during differentiation of 3T3-LI cells. FEBS Lett 1986; 199:103-106.
  • Watkins DC, Rapiejko PJ, Ros M, Wang Fl, Malbon CC. G-protein mRITA levels during adipocyte differentiation. Biochem Biophys Res Commun. 65:929-934.
  • Wang FI, Watkins DC, Malbon CC. Antisense oligodeoxynucleotides to Gs protein cx-subunit sequence accelerate differentiation of fibroblasts to adipocytes, nature 1992;358:334-337.
  • Denis-Ftenriot D., Lacasa D, Goldsmith PK, De Mazancourt P, Giudicelli Y. Site-related differences in G-protein a subunit expression during adipogenesis in vitro: Possible key role for Gq/I / a in the control of preadipocyte differentiation. Biochem Biophys Res Commun 1996:220:443-448.
  • Galvin-Parton PA, Watkins DC, Malbon CC. Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells. J Biol Chem 1990;265:17771-17774.
  • Gao P, Malbon CC. Differentation of F9 teratocarcinoma stem cells to primitive endoderm is regulated by the Gia2/Gsa axis via phospholipase C and not adenylyl cyclase. J Biol Chem 1996:2 71:3069 7-30698.
  • Amatruda TT, Steele DA, Zlepak VZ, Simon Ml. Cin 16, a G protein a subunit specifically expressed in hematopoietic cells. Proc ITatl Acad Sci USA 1991;88:5587-5591.
  • Meibner JD, Brown G A, Mueller WFI, Scheibe RJ. Retinoic acid -mediated decrease of Gas protein expression Involvement of Gas in the differentiation of tlL-60 myeloid cells. Exp Cell Res 1996:225:1 12-121.
  • Tiagata K, Okano Y, ITozawa Y. Identification of heterotrimetric GTP-binding proteins in human megakaryoblastic leukemia cell line, MEG-01, and their alteration during cellular differentiation. Life Sci 1995;57:1675-1681.
  • Kesselring F, Spicher K, Porzig FI. Changes in G protein pattern and in G protein -dependent signaling during erythopoietin- and dimethylsulfoxide- induced differentiation of murine erythroleukemia cells. Blood 1994;84:4088-4098.
  • Tenailleau S, Corre I, Flermouet S. Specific expression of heterotrimeric G proteins G ¡2 and G ¡g during human myeloid differentiation. Exp Flematol 1997;25:927-934.
  • Spiegel AM, Shenker A, Weinstein LS. Receptor- effector coupling by G-proteins: Implications for normal and abnormal signal transduction. Endocr Rev 1992;13:536-565.
  • Spiegel AM. Defects in G protein- coupled signal transduction in human disease. Annu Rev Physiol 1995;58:143-1 70.
  • Lyons J. Landis CA, Flarsh G, Vallar L et al. Two G protein oncogenes in human endocrine tumors. Science 1990;249:655-659.
  • dementi E, Malgaretti H, Meldolesi J, Taramelli R. A new constitutively activating mutation of the Gs protein a subunit-gsp oncogene is found in human pituitary tumors. Oncogene 1990;5:1059-1061.
  • OSullivan C, Barton CM, Staddon SL, Brown CL, Lemoine FIR. Activating point mutations of the gsp oncogene in human thyroid adenomas. Molecular Carcinogenesis 1991:4.345-349.
  • Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. IT Engl J Med 1991 ;325:1688-1695.
  • Scwindinger WF, Francomano CA, Levine MA. Idenfiction of a mutation in the gene encoding the a subunit of the stimulatory G protein of adenylyl cyclase in Me Cune- Albright Syndrome. Proc ITatl Acad Sci USA 1992;89:5152-5156.
  • Suarez FIG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. gsp mutations in human thyroid tumors. Oncogene 1991;6:677-679.
  • Tordjman K, Stern IT, Ouaknine G et al. Activating mutations of the Gsa gene in non-functioning pituitary tumors. J Clin Endocrinol Metab 1993;77:765-769.
  • Yoshimato K, Iwahana FI, Fukuda A, Sano T, Itakurra M. Rare mutations of the Gsa subunit gene in human endocrine tumors. Cancer 1993:72:1386- 1393.
  • Williamson EA, Daniels M, Foster S, Kelly WF, Kendall-Taylor P, Harris PE. Gsa and Cij2u mutations in clinically non-functioning pituitary tumors. Clin Endocrinol 1994;41:815-820.
  • Williamson EA, Ince PG, Flarrison D, Kendall-Taylor P, Harris PE. G-protein mutations in human pituitary and adrenocorticotrophic hormone-secreting adenomas. Eur. J. Clin Invest 1995;25:128-131.
  • Williamson EA, Johnson SJ, Foster S, Kendall-Taylor P, Harris PE. G-protein gene mutations in patients with multiple endocrinopathies. J Clin Endocrinol Metab 1995:80:1702-1705.
There are 38 citations in total.

Details

Journal Section Reviews
Authors

Beki Kan This is me

Publication Date December 3, 2016
Published in Issue Year 1999 Volume: 12 Issue: 1

Cite

APA Kan, B. (2016). G PROTEINS IN HEALTH AND DISEASE. Marmara Medical Journal, 12(1), 46-49.
AMA Kan B. G PROTEINS IN HEALTH AND DISEASE. Marmara Med J. June 2016;12(1):46-49.
Chicago Kan, Beki. “G PROTEINS IN HEALTH AND DISEASE”. Marmara Medical Journal 12, no. 1 (June 2016): 46-49.
EndNote Kan B (June 1, 2016) G PROTEINS IN HEALTH AND DISEASE. Marmara Medical Journal 12 1 46–49.
IEEE B. Kan, “G PROTEINS IN HEALTH AND DISEASE”, Marmara Med J, vol. 12, no. 1, pp. 46–49, 2016.
ISNAD Kan, Beki. “G PROTEINS IN HEALTH AND DISEASE”. Marmara Medical Journal 12/1 (June 2016), 46-49.
JAMA Kan B. G PROTEINS IN HEALTH AND DISEASE. Marmara Med J. 2016;12:46–49.
MLA Kan, Beki. “G PROTEINS IN HEALTH AND DISEASE”. Marmara Medical Journal, vol. 12, no. 1, 2016, pp. 46-49.
Vancouver Kan B. G PROTEINS IN HEALTH AND DISEASE. Marmara Med J. 2016;12(1):46-9.